Skip to main content

Research Ethics Board

We provide ethical review of research at BC Cancer.

The BC Cancer Research Ethics Board (REB) is one of six UBC-affiliated research ethics boards for research involving human participants. 

Introduction

The REB reviews clinical, epidemiological and behavioural adult oncology research projects, including basic science projects that use human materials. All research at BC Cancer involving humans or material and information derived from humans must be reviewed and approved by the REB before the project can be activated. 

The REB is comprised of members who among them pool extensive experience and knowledge in scientific investigations, cancer research, the experience of cancer patients and the ethical issues raised by research involving humans.

Members

The REB was implemented May 27, 2003. 

  • Chair: Dr. Karen Gelmon
  • Vice-Chair:  Dr Vivien Bramwell

 
Compliance

Compliance assurances

The REB complies with the US Department of Health and Human Services (DHHS) Code of Federal Regulations 45 CFR 46.103. 

These regulations state that every institution engaged in human subject research supported or conducted by the DHHS must have assurance of compliance approved by the US Office for Human Research Protections (OHRP/FDA.)

Federalwide Assurance (FWA) and Institutional Review Board (IRB) assurances with OHRP/FDA have been obtained for both BC Cancer and the BC Cancer Research Ethics Board (REB). These assurances are listed here (REBs in Canada are referred to as IRBs in the US.)

Institutional Organization: BC Cancer Agency (IORG #IORG0003172) 

Assurance

  • Type of Assurance: Federalwide Assurance for "BC Cancer Agency"
  • Assurance Numbers: FWA00001149
  • Expiry Date: Mar 9, 2021

Assurance

  • Type of Assurance: IRB Assurance for "B.C. Cancer Agency IRB #1"
  • Assurance Numbers: IRB00003797
  • Expiry Date: May 15, 2020 
For details or confirmation of BC Cancer approved OHRP/FDA assurances, go to the Office for Human Research Protections database and search by entering the IORG, FWA or IRB number.

UBC assurance of compliance statement

The BC Cancer Research Ethics Board is a UBC-affilated REB. 

UBC Office of Research Services provides regulatory oversight for all UBC affiliated REBs. Read the Assurance of Compliance Statement.  

Contact

 
Please contact a REB Coordinator (and quote the project number - RISe # e.g. H0x-yyyyy) for all questions relating to:
  • pre-review of all full board and delegated/minimal risk
  • post-review documentation of all full board REB decisions (e.g., deferrals, provisos, amendments, and renewals)

REB Coordinators

Evani Goll

E-mail:  reb@bccancer.bc.ca
Telephone: (604) 877-6223

Naama Rozen

E-mail: reb@bccancer.bc.ca
Telephone: (604) 877 6289

Jessica Gagliardi

E-mail: reb@bccancer.bc.ca
Telephone: (604) 877 6283
 

 

Please contact the REB Manager for questions relating to:

  • compliance with local, national and international policies and legislation
  • activities, procedures and direction of the REB and staff
  • ethics queries
  • training
  • adverse events 

REB Manager

Dr. Kristie Westerlaken 

E-mail: Kristie.Westerlaken@bccancer.bc.ca
Telephone: 604-877-6284

BC Cancer
Fairmont Medical Building, Suite 1315 
750 West Broadway
Vancouver, B.C. V5Z 1J3
Fax: (604) 708-2132
email: reb@bccancer.bc.ca

 

 

The Researcher Information Services system (RISe) is used for both the submission and approval process of all research ethics applications submitted to the REB.

If you are a first-time user, please register with RISe to create an account.

Instructions on the use and application of RISe are on the site and in the site and embedded in the application itself.

For technical assistance with the RISe system (quote RISe project number if applicable):

 


Tab Heading
SOURCE: Research Ethics Board ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer. All Rights Reserved.

    Copyright © 2018 Provincial Health Services Authority